Table of Contents Chapter 1 Overview of Antivenom 1.1 Definition of Antivenom in This Report 1.2 Commercial Types of Antivenom 1.2.1 Humans 1.2.2 Animals 1.3 Downstream Application of Antivenom 1.3.1 Monovalent 1.3.2 Polyvalent 1.4 Development History of Antivenom 1.5 Market Status and Trend of Antivenom 2013-2023 1.5.1 Global Antivenom Market Status and Trend 2013-2023 1.5.2 Regional Antivenom Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Antivenom 2013-2017 2.2 Sales Market of Antivenom by Regions 2.2.1 Sales Volume of Antivenom by Regions 2.2.2 Sales Value of Antivenom by Regions 2.3 Production Market of Antivenom by Regions 2.4 Global Market Forecast of Antivenom 2018-2023 2.4.1 Global Market Forecast of Antivenom 2018-2023 2.4.2 Market Forecast of Antivenom by Regions 2018-2023 Chapter 3 Global Market Status and Forecast by Types 3.1 Sales Volume of Antivenom by Types 3.2 Sales Value of Antivenom by Types 3.3 Market Forecast of Antivenom by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Global Sales Volume of Antivenom by Downstream Industry 4.2 Global Market Forecast of Antivenom by Downstream Industry Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry 5.1 North America Antivenom Market Status by Countries 5.1.1 North America Antivenom Sales by Countries (2013-2017) 5.1.2 North America Antivenom Revenue by Countries (2013-2017) 5.1.3 United States Antivenom Market Status (2013-2017) 5.1.4 Canada Antivenom Market Status (2013-2017) 5.1.5 Mexico Antivenom Market Status (2013-2017) 5.2 North America Antivenom Market Status by Manufacturers 5.3 North America Antivenom Market Status by Type (2013-2017) 5.3.1 North America Antivenom Sales by Type (2013-2017) 5.3.2 North America Antivenom Revenue by Type (2013-2017) 5.4 North America Antivenom Market Status by Downstream Industry (2013-2017) Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry 6.1 Europe Antivenom Market Status by Countries 6.1.1 Europe Antivenom Sales by Countries (2013-2017) 6.1.2 Europe Antivenom Revenue by Countries (2013-2017) 6.1.3 Germany Antivenom Market Status (2013-2017) 6.1.4 UK Antivenom Market Status (2013-2017) 6.1.5 France Antivenom Market Status (2013-2017) 6.1.6 Italy Antivenom Market Status (2013-2017) 6.1.7 Russia Antivenom Market Status (2013-2017) 6.1.8 Spain Antivenom Market Status (2013-2017) 6.1.9 Benelux Antivenom Market Status (2013-2017) 6.2 Europe Antivenom Market Status by Manufacturers 6.3 Europe Antivenom Market Status by Type (2013-2017) 6.3.1 Europe Antivenom Sales by Type (2013-2017) 6.3.2 Europe Antivenom Revenue by Type (2013-2017) 6.4 Europe Antivenom Market Status by Downstream Industry (2013-2017) Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry 7.1 Asia Pacific Antivenom Market Status by Countries 7.1.1 Asia Pacific Antivenom Sales by Countries (2013-2017) 7.1.2 Asia Pacific Antivenom Revenue by Countries (2013-2017) 7.1.3 China Antivenom Market Status (2013-2017) 7.1.4 Japan Antivenom Market Status (2013-2017) 7.1.5 India Antivenom Market Status (2013-2017) 7.1.6 Southeast Asia Antivenom Market Status (2013-2017) 7.1.7 Australia Antivenom Market Status (2013-2017) 7.2 Asia Pacific Antivenom Market Status by Manufacturers 7.3 Asia Pacific Antivenom Market Status by Type (2013-2017) 7.3.1 Asia Pacific Antivenom Sales by Type (2013-2017) 7.3.2 Asia Pacific Antivenom Revenue by Type (2013-2017) 7.4 Asia Pacific Antivenom Market Status by Downstream Industry (2013-2017) Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry 8.1 Latin America Antivenom Market Status by Countries 8.1.1 Latin America Antivenom Sales by Countries (2013-2017) 8.1.2 Latin America Antivenom Revenue by Countries (2013-2017) 8.1.3 Brazil Antivenom Market Status (2013-2017) 8.1.4 Argentina Antivenom Market Status (2013-2017) 8.1.5 Colombia Antivenom Market Status (2013-2017) 8.2 Latin America Antivenom Market Status by Manufacturers 8.3 Latin America Antivenom Market Status by Type (2013-2017) 8.3.1 Latin America Antivenom Sales by Type (2013-2017) 8.3.2 Latin America Antivenom Revenue by Type (2013-2017) 8.4 Latin America Antivenom Market Status by Downstream Industry (2013-2017) Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry 9.1 Middle East and Africa Antivenom Market Status by Countries 9.1.1 Middle East and Africa Antivenom Sales by Countries (2013-2017) 9.1.2 Middle East and Africa Antivenom Revenue by Countries (2013-2017) 9.1.3 Middle East Antivenom Market Status (2013-2017) 9.1.4 Africa Antivenom Market Status (2013-2017) 9.2 Middle East and Africa Antivenom Market Status by Manufacturers 9.3 Middle East and Africa Antivenom Market Status by Type (2013-2017) 9.3.1 Middle East and Africa Antivenom Sales by Type (2013-2017) 9.3.2 Middle East and Africa Antivenom Revenue by Type (2013-2017) 9.4 Middle East and Africa Antivenom Market Status by Downstream Industry (2013-2017) Chapter 10 Market Driving Factor Analysis of Antivenom 10.1 Global Economy Situation and Trend Overview 10.2 Antivenom Downstream Industry Situation and Trend Overview Chapter 11 Antivenom Market Competition Status by Major Manufacturers 11.1 Production Volume of Antivenom by Major Manufacturers 11.2 Production Value of Antivenom by Major Manufacturers 11.3 Basic Information of Antivenom by Major Manufacturers 11.3.1 Headquarters Location and Established Time of Antivenom Major Manufacturer 11.3.2 Employees and Revenue Level of Antivenom Major Manufacturer 11.4 Market Competition News and Trend 11.4.1 Merger, Consolidation or Acquisition News 11.4.2 Investment or Disinvestment News 11.4.3 New Product Development and Launch Chapter 12 Antivenom Major Manufacturers Introduction and Market Data 12.1 Merck 12.1.1 Company profile 12.1.2 Representative Antivenom Product 12.1.3 Antivenom Sales, Revenue, Price and Gross Margin of Merck 12.2 Summerland Serums (AU) 12.2.1 Company profile 12.2.2 Representative Antivenom Product 12.2.3 Antivenom Sales, Revenue, Price and Gross Margin of Summerland Serums (AU) 12.3 Haffkine Bio Pharmaceutical 12.3.1 Company profile 12.3.2 Representative Antivenom Product 12.3.3 Antivenom Sales, Revenue, Price and Gross Margin of Haffkine Bio Pharmaceutical 12.4 MicroPharm 12.4.1 Company profile 12.4.2 Representative Antivenom Product 12.4.3 Antivenom Sales, Revenue, Price and Gross Margin of MicroPharm 12.5 CSL (AU) 12.5.1 Company profile 12.5.2 Representative Antivenom Product 12.5.3 Antivenom Sales, Revenue, Price and Gross Margin of CSL (AU) 12.6 SAVP 12.6.1 Company profile 12.6.2 Representative Antivenom Product 12.6.3 Antivenom Sales, Revenue, Price and Gross Margin of SAVP 12.7 Flynn Pharma 12.7.1 Company profile 12.7.2 Representative Antivenom Product 12.7.3 Antivenom Sales, Revenue, Price and Gross Margin of Flynn Pharma 12.8 Serum 12.8.1 Company profile 12.8.2 Representative Antivenom Product 12.8.3 Antivenom Sales, Revenue, Price and Gross Margin of Serum Chapter 13 Upstream and Downstream Market Analysis of Antivenom 13.1 Industry Chain of Antivenom 13.2 Upstream Market and Representative Companies Analysis 13.3 Downstream Market and Representative Companies Analysis Chapter 14 Cost and Gross Margin Analysis of Antivenom 14.1 Cost Structure Analysis of Antivenom 14.2 Raw Materials Cost Analysis of Antivenom 14.3 Labor Cost Analysis of Antivenom 14.4 Manufacturing Expenses Analysis of Antivenom Chapter 15 Report Conclusion Chapter 16 Research Methodology and Reference 16.1 Methodology/Research Approach 16.1.1 Research Programs/Design 16.1.2 Market Size Estimation 16.1.3 Market Breakdown and Data Triangulation 16.2 Data Source 16.2.1 Secondary Sources 16.2.2 Primary Sources 16.3 Reference

List of Tables Table Advantage and Disadvantage of Humans Table Advantage and Disadvantage of Animals Table Sales Volume of Antivenom by Regions 2013-2017 Table Sales Value of Antivenom by Regions 2013-2017 Table Production Volume of Antivenom by Regions 2013-2017 Table Global Sales Volume of Antivenom by Regions 2018-2023 Table Global Sales Value of Antivenom by Regions 2018-2023 Table Global Production Volume of Antivenom by Regions 2018-2023 Table Sales Volume of Antivenom by Types 2013-2017 Table Sales Value of Antivenom by Types 2013-2017 Table Sales Volume Forecast of Antivenom by Types 2018-2023 Table Sales Value Forecast of Antivenom by Types 2018-2023 Table Sales Volume of Antivenom by Downstream Industry 2013-2017 Table Sales Volume Forecast of Antivenom by Downstream Industry 2018-2023 Table North America Antivenom Sales by Countries (2013-2017) Table North America Antivenom Sales Share by Countries (2013-2017) Table North America Antivenom Revenue by Countries (2013-2017) Table North America Antivenom Revenue Market Share by Countries (2013-2017) Table North America Antivenom Sales by Type (2013-2017) Table North America Antivenom Sales Share by Type (2013-2017) Table North America Antivenom Revenue by Type (2013-2017) Table North America Antivenom Revenue Share by Type (2013-2017) Table North America Antivenom Sales by Downstream Industry (2013-2017) Table North America Antivenom Sales Share by Downstream Industry (2013-2017) Table Europe Antivenom Sales by Countries (2013-2017) Table Europe Antivenom Sales Share by Countries (2013-2017) Table Europe Antivenom Revenue by Countries (2013-2017) Table Europe Antivenom Revenue Market Share by Countries (2013-2017) Table Europe Antivenom Sales by Type (2013-2017) Table Europe Antivenom Sales Share by Type (2013-2017) Table Europe Antivenom Revenue by Type (2013-2017) Table Europe Antivenom Revenue Share by Type (2013-2017) Table Europe Antivenom Sales by Downstream Industry (2013-2017) Table Europe Antivenom Sales Share by Downstream Industry (2013-2017) Table Asia Pacific Antivenom Sales by Countries (2013-2017) Table Asia Pacific Antivenom Sales Share by Countries (2013-2017) Table Asia Pacific Antivenom Revenue by Countries (2013-2017) Table Asia Pacific Antivenom Revenue Market Share by Countries (2013-2017) Table Asia Pacific Antivenom Sales by Type (2013-2017) Table Asia Pacific Antivenom Sales Share by Type (2013-2017) Table Asia Pacific Antivenom Revenue by Type (2013-2017) Table Asia Pacific Antivenom Revenue Share by Type (2013-2017) Table Asia Pacific Antivenom Sales by Downstream Industry (2013-2017) Table Asia Pacific Antivenom Sales Share by Downstream Industry (2013-2017) Table Latin America Antivenom Sales by Countries (2013-2017) Table Latin America Antivenom Sales Share by Countries (2013-2017) Table Latin America Antivenom Revenue by Countries (2013-2017) Table Latin America Antivenom Revenue Market Share by Countries (2013-2017) Table Latin America Antivenom Sales by Type (2013-2017) Table Latin America Antivenom Sales Share by Type (2013-2017) Table Latin America Antivenom Revenue by Type (2013-2017) Table Latin America Antivenom Revenue Share by Type (2013-2017) Table Latin America Antivenom Sales by Downstream Industry (2013-2017) Table Latin America Antivenom Sales Share by Downstream Industry (2013-2017) Table Middle East and Africa Antivenom Sales by Regions (2013-2017) Table Middle East and Africa Antivenom Sales Share by Regions (2013-2017) Table Middle East and Africa Antivenom Revenue by Regions (2013-2017) Table Middle East and Africa Antivenom Revenue Market Share by Regions (2013-2017) Table Middle East and Africa Antivenom Sales by Type (2013-2017) Table Middle East and Africa Antivenom Sales Share by Type (2013-2017) Table Middle East and Africa Antivenom Revenue by Type (2013-2017) Table Middle East and Africa Antivenom Revenue Share by Type (2013-2017) Table Middle East and Africa Antivenom Sales by Downstream Industry (2013-2017) Table Middle East and Africa Antivenom Sales Share by Downstream Industry (2013-2017) Table Production Volume of Antivenom by Major Manufacturers 2013-2017 Table Production Value of Antivenom by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Antivenom Major Manufacturer Table Employees and Revenue Level of Antivenom Major Manufacturer Table Representative Antivenom Product One of Merck Table Representative Antivenom Product Two of Merck Table Antivenom Sales, Revenue, Price and Gross Margin of Merck 2013-2017 Table Representative Antivenom Product One of Summerland Serums (AU) Table Representative Antivenom Product Two of Summerland Serums (AU) Table Antivenom Sales, Revenue, Price and Gross Margin of Summerland Serums (AU) 2013-2017 Table Representative Antivenom Product One of Haffkine Bio Pharmaceutical Table Representative Antivenom Product Two of Haffkine Bio Pharmaceutical Table Antivenom Sales, Revenue, Price and Gross Margin of Haffkine Bio Pharmaceutical 2013-2017 Table Representative Antivenom Product One of MicroPharm Table Representative Antivenom Product Two of MicroPharm Table Antivenom Sales, Revenue, Price and Gross Margin of MicroPharm 2013-2017 Table Representative Antivenom Product One of CSL (AU) Table Representative Antivenom Product Two of CSL (AU) Table Antivenom Sales, Revenue, Price and Gross Margin of CSL (AU) 2013-2017 Table Representative Antivenom Product One of SAVP Table Representative Antivenom Product Two of SAVP Table Antivenom Sales, Revenue, Price and Gross Margin of SAVP 2013-2017 Table Representative Antivenom Product One of Flynn Pharma Table Representative Antivenom Product Two of Flynn Pharma Table Antivenom Sales, Revenue, Price and Gross Margin of Flynn Pharma 2013-2017 Table Representative Antivenom Product One of Serum Table Representative Antivenom Product Two of Serum Table Antivenom Sales, Revenue, Price and Gross Margin of Serum 2013-2017